

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of B cell receptor signaling pathway (GO:0050855) | 7.22311512 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.72719912 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 5.58657169 |
| 4 | immunoglobulin mediated immune response (GO:0016064) | 4.95184400 |
| 5 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.90691522 |
| 6 | neutrophil activation (GO:0042119) | 4.62410741 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.54250368 |
| 8 | regulation of T cell tolerance induction (GO:0002664) | 4.52148778 |
| 9 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.48200761 |
| 10 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.47145186 |
| 11 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.47145186 |
| 12 | mast cell activation (GO:0045576) | 4.46440937 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.42559772 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.38498872 |
| 15 | respiratory burst (GO:0045730) | 4.35168509 |
| 16 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.32640894 |
| 17 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.32624489 |
| 18 | actin nucleation (GO:0045010) | 4.32229803 |
| 19 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.32178693 |
| 20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.32117465 |
| 21 | negative regulation of cell killing (GO:0031342) | 4.32117465 |
| 22 | negative T cell selection (GO:0043383) | 4.28952560 |
| 23 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.20285343 |
| 24 | cellular response to interleukin-15 (GO:0071350) | 4.19494087 |
| 25 | regulation of tolerance induction (GO:0002643) | 4.18411108 |
| 26 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.13796037 |
| 27 | granulocyte activation (GO:0036230) | 4.09206961 |
| 28 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.08030023 |
| 29 | positive T cell selection (GO:0043368) | 4.03178898 |
| 30 | T cell costimulation (GO:0031295) | 3.97961917 |
| 31 | B cell mediated immunity (GO:0019724) | 3.94800489 |
| 32 | positive thymic T cell selection (GO:0045059) | 3.94060547 |
| 33 | response to interleukin-15 (GO:0070672) | 3.93087728 |
| 34 | lymphocyte costimulation (GO:0031294) | 3.92970317 |
| 35 | T cell receptor signaling pathway (GO:0050852) | 3.78466582 |
| 36 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.77125632 |
| 37 | tolerance induction (GO:0002507) | 3.75048199 |
| 38 | negative thymic T cell selection (GO:0045060) | 3.71553907 |
| 39 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.70348597 |
| 40 | T cell migration (GO:0072678) | 3.67736152 |
| 41 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.67012547 |
| 42 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.66201065 |
| 43 | regulation of hypersensitivity (GO:0002883) | 3.63169289 |
| 44 | positive regulation of tolerance induction (GO:0002645) | 3.57598966 |
| 45 | regulation of regulatory T cell differentiation (GO:0045589) | 3.54883813 |
| 46 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.54837109 |
| 47 | cellular extravasation (GO:0045123) | 3.51971400 |
| 48 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.51146090 |
| 49 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.50669868 |
| 50 | cellular response to type I interferon (GO:0071357) | 3.49927240 |
| 51 | type I interferon signaling pathway (GO:0060337) | 3.49927240 |
| 52 | leukocyte aggregation (GO:0070486) | 3.46288870 |
| 53 | response to type I interferon (GO:0034340) | 3.45435273 |
| 54 | positive regulation of mast cell activation (GO:0033005) | 3.42989486 |
| 55 | myeloid cell activation involved in immune response (GO:0002275) | 3.41942713 |
| 56 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.37063224 |
| 57 | microglial cell activation (GO:0001774) | 3.35101363 |
| 58 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.33376126 |
| 59 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.30879279 |
| 60 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.29932693 |
| 61 | positive regulation of mast cell degranulation (GO:0043306) | 3.29724513 |
| 62 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.29724513 |
| 63 | positive regulation of cell killing (GO:0031343) | 3.24282956 |
| 64 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.24126556 |
| 65 | regulation of interleukin-8 secretion (GO:2000482) | 3.22474890 |
| 66 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.22227864 |
| 67 | detection of molecule of bacterial origin (GO:0032490) | 3.21315860 |
| 68 | regulation of mast cell activation (GO:0033003) | 3.20011933 |
| 69 | thymic T cell selection (GO:0045061) | 3.18607232 |
| 70 | T cell selection (GO:0045058) | 3.18086772 |
| 71 | regulation of cell killing (GO:0031341) | 3.15535106 |
| 72 | negative regulation of T cell mediated immunity (GO:0002710) | 3.12774757 |
| 73 | regulation of gamma-delta T cell activation (GO:0046643) | 3.12160843 |
| 74 | positive regulation of interleukin-1 beta production (GO:0032731) | 3.08205753 |
| 75 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.07219510 |
| 76 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.07033260 |
| 77 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.06777524 |
| 78 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.04242969 |
| 79 | mast cell activation involved in immune response (GO:0002279) | 3.02668589 |
| 80 | mast cell degranulation (GO:0043303) | 3.02668589 |
| 81 | lymphocyte chemotaxis (GO:0048247) | 3.01609307 |
| 82 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.01523392 |
| 83 | negative regulation of interleukin-12 production (GO:0032695) | 2.98464030 |
| 84 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.98442508 |
| 85 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.98442508 |
| 86 | modulation by symbiont of host immune response (GO:0052553) | 2.98442508 |
| 87 | positive regulation by symbiont of host defense response (GO:0052509) | 2.98442508 |
| 88 | modulation by symbiont of host defense response (GO:0052031) | 2.98442508 |
| 89 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.98442508 |
| 90 | response to peptidoglycan (GO:0032494) | 2.97825382 |
| 91 | leukocyte degranulation (GO:0043299) | 2.96702166 |
| 92 | positive regulation of interleukin-1 production (GO:0032732) | 2.94926994 |
| 93 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.94073303 |
| 94 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.93769329 |
| 95 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.92785185 |
| 96 | positive regulation of fatty acid oxidation (GO:0046321) | 2.91232370 |
| 97 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.89560028 |
| 98 | detection of other organism (GO:0098543) | 2.89293741 |
| 99 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.88205686 |
| 100 | positive regulation of type 2 immune response (GO:0002830) | 2.86639353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.71463665 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.49254926 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.47405533 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.20430221 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.51568709 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.36814543 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.48291999 |
| 8 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.20587225 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.15978897 |
| 10 | MYB_26560356_Chip-Seq_TH2_Human | 2.93212249 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.76728525 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.74863526 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.70491383 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.60231365 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.50140457 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.45730140 |
| 17 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.43808329 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31546852 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.21288402 |
| 20 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.13506195 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.08860478 |
| 22 | GATA3_26560356_Chip-Seq_TH2_Human | 2.08101883 |
| 23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.06395643 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.95956381 |
| 25 | MYB_26560356_Chip-Seq_TH1_Human | 1.93809606 |
| 26 | VDR_22108803_ChIP-Seq_LS180_Human | 1.90739880 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.88780622 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.82142129 |
| 29 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80858549 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.73796495 |
| 31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.66973815 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.63771628 |
| 33 | UTX_26944678_Chip-Seq_JUKART_Human | 1.59515275 |
| 34 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.55660981 |
| 35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46712569 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.45338883 |
| 37 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.44272864 |
| 38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.37952317 |
| 39 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36196926 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33926548 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.33238030 |
| 42 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.32382199 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30053679 |
| 44 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.29024206 |
| 45 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27832016 |
| 46 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.24558132 |
| 47 | MAF_26560356_Chip-Seq_TH2_Human | 1.22312484 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18768250 |
| 49 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15232148 |
| 50 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.14457945 |
| 51 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.14058506 |
| 52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.11933913 |
| 53 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.09095049 |
| 54 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07952587 |
| 55 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04556113 |
| 56 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.04452023 |
| 57 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02577619 |
| 58 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00600794 |
| 59 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.99891095 |
| 60 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99783832 |
| 61 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97930179 |
| 62 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.97418626 |
| 63 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95679407 |
| 64 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.94728887 |
| 65 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.94692956 |
| 66 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.93876733 |
| 67 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.93501883 |
| 68 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.92498111 |
| 69 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.91830726 |
| 70 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.90356713 |
| 71 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.89955543 |
| 72 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89022640 |
| 73 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.87363769 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86377619 |
| 75 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85507547 |
| 76 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83491734 |
| 77 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83179749 |
| 78 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.82458211 |
| 79 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.78603587 |
| 80 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.78504074 |
| 81 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.78411907 |
| 82 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.78310962 |
| 83 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.78310962 |
| 84 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.77989062 |
| 85 | GATA3_26560356_Chip-Seq_TH1_Human | 0.77324346 |
| 86 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.77279230 |
| 87 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.76455847 |
| 88 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.75957746 |
| 89 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.75248128 |
| 90 | * FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.74728825 |
| 91 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74082291 |
| 92 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.73941658 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73264571 |
| 94 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.72835934 |
| 95 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.72712136 |
| 96 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.72054141 |
| 97 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.69873312 |
| 98 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.69650658 |
| 99 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.69237822 |
| 100 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.68280872 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 5.07243709 |
| 2 | MP0005671_abnormal_response_to | 4.77591669 |
| 3 | MP0001835_abnormal_antigen_presentation | 4.46232212 |
| 4 | MP0003724_increased_susceptibility_to | 4.26266869 |
| 5 | MP0009785_altered_susceptibility_to | 3.93222543 |
| 6 | MP0001873_stomach_inflammation | 3.35064606 |
| 7 | MP0003436_decreased_susceptibility_to | 3.25573811 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.21140022 |
| 9 | MP0001800_abnormal_humoral_immune | 3.02774452 |
| 10 | MP0005025_abnormal_response_to | 2.90194017 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.68689958 |
| 12 | MP0002723_abnormal_immune_serum | 2.68549776 |
| 13 | MP0006082_CNS_inflammation | 2.65673585 |
| 14 | MP0000685_abnormal_immune_system | 2.54419831 |
| 15 | MP0005387_immune_system_phenotype | 2.54273313 |
| 16 | MP0001790_abnormal_immune_system | 2.54273313 |
| 17 | MP0002419_abnormal_innate_immunity | 2.50795657 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.48250849 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.47886747 |
| 20 | MP0001819_abnormal_immune_cell | 2.45267002 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.37112479 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.36887195 |
| 23 | MP0002166_altered_tumor_susceptibility | 2.19349026 |
| 24 | MP0009764_decreased_sensitivity_to | 2.07763098 |
| 25 | MP0010155_abnormal_intestine_physiology | 2.05752400 |
| 26 | MP0001533_abnormal_skeleton_physiology | 1.99133313 |
| 27 | MP0003303_peritoneal_inflammation | 1.90157947 |
| 28 | MP0005464_abnormal_platelet_physiology | 1.89513449 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.85271546 |
| 30 | MP0003075_altered_response_to | 1.81772106 |
| 31 | MP0000716_abnormal_immune_system | 1.80105376 |
| 32 | MP0002006_tumorigenesis | 1.80093979 |
| 33 | MP0003866_abnormal_defecation | 1.78452569 |
| 34 | MP0002405_respiratory_system_inflammati | 1.76477278 |
| 35 | MP0002398_abnormal_bone_marrow | 1.74736981 |
| 36 | MP0004947_skin_inflammation | 1.68009025 |
| 37 | MP0003806_abnormal_nucleotide_metabolis | 1.66368098 |
| 38 | MP0003045_fibrosis | 1.48516600 |
| 39 | MP0000858_altered_metastatic_potential | 1.48178044 |
| 40 | MP0003448_altered_tumor_morphology | 1.43487411 |
| 41 | MP0005166_decreased_susceptibility_to | 1.40963200 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.38879468 |
| 43 | MP0002933_joint_inflammation | 1.37342464 |
| 44 | MP0008469_abnormal_protein_level | 1.36429975 |
| 45 | MP0002429_abnormal_blood_cell | 1.35770258 |
| 46 | MP0002722_abnormal_immune_system | 1.31687605 |
| 47 | MP0000703_abnormal_thymus_morphology | 1.23920893 |
| 48 | MP0005075_abnormal_melanosome_morpholog | 1.23701473 |
| 49 | MP0002277_abnormal_respiratory_mucosa | 1.21581842 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.16617150 |
| 51 | MP0002132_abnormal_respiratory_system | 1.08398625 |
| 52 | MP0009763_increased_sensitivity_to | 1.06802428 |
| 53 | MP0008260_abnormal_autophagy | 1.04449855 |
| 54 | MP0009379_abnormal_foot_pigmentation | 1.04211631 |
| 55 | MP0001663_abnormal_digestive_system | 0.98437299 |
| 56 | MP0003252_abnormal_bile_duct | 0.98233445 |
| 57 | MP0000569_abnormal_digit_pigmentation | 0.94629494 |
| 58 | MP0000343_altered_response_to | 0.89299677 |
| 59 | MP0003646_muscle_fatigue | 0.88285005 |
| 60 | MP0001765_abnormal_ion_homeostasis | 0.86105311 |
| 61 | MP0008004_abnormal_stomach_pH | 0.85202812 |
| 62 | MP0003183_abnormal_peptide_metabolism | 0.84762187 |
| 63 | MP0003300_gastrointestinal_ulcer | 0.79741232 |
| 64 | MP0001853_heart_inflammation | 0.77969211 |
| 65 | MP0008961_abnormal_basal_metabolism | 0.75971389 |
| 66 | MP0004883_abnormal_blood_vessel | 0.74928276 |
| 67 | MP0002693_abnormal_pancreas_physiology | 0.73144419 |
| 68 | MP0005390_skeleton_phenotype | 0.72758342 |
| 69 | MP0005397_hematopoietic_system_phenotyp | 0.72323930 |
| 70 | MP0001545_abnormal_hematopoietic_system | 0.72323930 |
| 71 | MP0004381_abnormal_hair_follicle | 0.70960309 |
| 72 | MP0005645_abnormal_hypothalamus_physiol | 0.67826149 |
| 73 | MP0001666_abnormal_nutrient_absorption | 0.66217321 |
| 74 | MP0003690_abnormal_glial_cell | 0.64134098 |
| 75 | MP0002998_abnormal_bone_remodeling | 0.63020758 |
| 76 | MP0009278_abnormal_bone_marrow | 0.62082473 |
| 77 | MP0003283_abnormal_digestive_organ | 0.62051694 |
| 78 | MP0003191_abnormal_cellular_cholesterol | 0.61644806 |
| 79 | MP0003938_abnormal_ear_development | 0.61146319 |
| 80 | MP0003638_abnormal_response/metabolism_ | 0.57943901 |
| 81 | MP0005164_abnormal_response_to | 0.57523795 |
| 82 | MP0002168_other_aberrant_phenotype | 0.56302226 |
| 83 | MP0006036_abnormal_mitochondrial_physio | 0.55953830 |
| 84 | MP0005381_digestive/alimentary_phenotyp | 0.55793944 |
| 85 | MP0000249_abnormal_blood_vessel | 0.55259778 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.52520362 |
| 87 | MP0000920_abnormal_myelination | 0.51995044 |
| 88 | MP0005310_abnormal_salivary_gland | 0.51872706 |
| 89 | MP0002138_abnormal_hepatobiliary_system | 0.51347096 |
| 90 | MP0001851_eye_inflammation | 0.50918698 |
| 91 | MP0002009_preneoplasia | 0.50891544 |
| 92 | MP0002136_abnormal_kidney_physiology | 0.49932560 |
| 93 | MP0002019_abnormal_tumor_incidence | 0.49333434 |
| 94 | MP0005551_abnormal_eye_electrophysiolog | 0.48483231 |
| 95 | MP0000015_abnormal_ear_pigmentation | 0.47800243 |
| 96 | MP0004742_abnormal_vestibular_system | 0.47568576 |
| 97 | MP0001485_abnormal_pinna_reflex | 0.46347332 |
| 98 | MP0009840_abnormal_foam_cell | 0.45621480 |
| 99 | MP0008875_abnormal_xenobiotic_pharmacok | 0.45508621 |
| 100 | MP0005174_abnormal_tail_pigmentation | 0.45038413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.70559300 |
| 2 | B lymphocytopenia (HP:0010976) | 5.20011202 |
| 3 | Abnormality of macrophages (HP:0004311) | 5.10799125 |
| 4 | IgG deficiency (HP:0004315) | 5.10234364 |
| 5 | Stomatitis (HP:0010280) | 4.95303543 |
| 6 | Increased IgM level (HP:0003496) | 4.86939712 |
| 7 | Abnormality of B cell number (HP:0010975) | 4.83720879 |
| 8 | Autoimmune hemolytic anemia (HP:0001890) | 4.75611485 |
| 9 | Gastrointestinal infarctions (HP:0005244) | 4.70305374 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 4.56152677 |
| 11 | Obstructive lung disease (HP:0006536) | 4.56152677 |
| 12 | Myositis (HP:0100614) | 4.27061502 |
| 13 | T lymphocytopenia (HP:0005403) | 4.20692663 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 4.10686141 |
| 15 | Meningitis (HP:0001287) | 4.00832439 |
| 16 | Abnormality of T cell number (HP:0011839) | 3.95749708 |
| 17 | Abnormality of the prostate (HP:0008775) | 3.90776633 |
| 18 | Eczematoid dermatitis (HP:0000976) | 3.81062221 |
| 19 | Chest pain (HP:0100749) | 3.72371184 |
| 20 | Recurrent bacterial skin infections (HP:0005406) | 3.63527466 |
| 21 | Encephalitis (HP:0002383) | 3.62880973 |
| 22 | Recurrent abscess formation (HP:0002722) | 3.58262189 |
| 23 | Gangrene (HP:0100758) | 3.55423694 |
| 24 | Orchitis (HP:0100796) | 3.53185731 |
| 25 | Hypoproteinemia (HP:0003075) | 3.52843609 |
| 26 | Retrobulbar optic neuritis (HP:0100654) | 3.50025937 |
| 27 | Optic neuritis (HP:0100653) | 3.50025937 |
| 28 | Pulmonary infiltrates (HP:0002113) | 3.39936123 |
| 29 | Hemoptysis (HP:0002105) | 3.36958989 |
| 30 | Vasculitis (HP:0002633) | 3.33828612 |
| 31 | Aplastic anemia (HP:0001915) | 3.32008160 |
| 32 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.25834407 |
| 33 | Severe combined immunodeficiency (HP:0004430) | 3.16395455 |
| 34 | Recurrent bronchitis (HP:0002837) | 3.12293150 |
| 35 | Ureteral stenosis (HP:0000071) | 3.11508959 |
| 36 | Pulmonary embolism (HP:0002204) | 3.05786092 |
| 37 | Arterial thrombosis (HP:0004420) | 3.03362429 |
| 38 | Acute hepatic failure (HP:0006554) | 3.01958383 |
| 39 | Recurrent fungal infections (HP:0002841) | 2.99061051 |
| 40 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.98992800 |
| 41 | Recurrent cutaneous fungal infections (HP:0011370) | 2.98992800 |
| 42 | Diplopia (HP:0000651) | 2.90376637 |
| 43 | Abnormality of binocular vision (HP:0011514) | 2.90376637 |
| 44 | Hypergammaglobulinemia (HP:0010702) | 2.89663363 |
| 45 | Ureteral obstruction (HP:0006000) | 2.85575561 |
| 46 | Recurrent skin infections (HP:0001581) | 2.85225388 |
| 47 | Epistaxis (HP:0000421) | 2.82403562 |
| 48 | Thyroiditis (HP:0100646) | 2.77321344 |
| 49 | Abnormality of T cells (HP:0002843) | 2.74052085 |
| 50 | Lymphopenia (HP:0001888) | 2.71805198 |
| 51 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.70136139 |
| 52 | Interstitial pulmonary disease (HP:0006530) | 2.63675116 |
| 53 | Combined immunodeficiency (HP:0005387) | 2.59195219 |
| 54 | Polyneuropathy (HP:0001271) | 2.56552112 |
| 55 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.49090569 |
| 56 | Keratoconjunctivitis sicca (HP:0001097) | 2.48166677 |
| 57 | Anorexia (HP:0002039) | 2.43680081 |
| 58 | Skin rash (HP:0000988) | 2.43344865 |
| 59 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.42069448 |
| 60 | Abnormality of the pleura (HP:0002103) | 2.38069200 |
| 61 | Keratoconjunctivitis (HP:0001096) | 2.37405326 |
| 62 | Severe visual impairment (HP:0001141) | 2.36437716 |
| 63 | Gingival bleeding (HP:0000225) | 2.34755491 |
| 64 | Decreased central vision (HP:0007663) | 2.32534816 |
| 65 | Abnormality of male internal genitalia (HP:0000022) | 2.30015720 |
| 66 | Glomerulopathy (HP:0100820) | 2.29685390 |
| 67 | Pancytopenia (HP:0001876) | 2.29232969 |
| 68 | Leukocytosis (HP:0001974) | 2.28315085 |
| 69 | IgM deficiency (HP:0002850) | 2.23700574 |
| 70 | Prolonged bleeding time (HP:0003010) | 2.21225880 |
| 71 | Urticaria (HP:0001025) | 2.18323933 |
| 72 | Amaurosis fugax (HP:0100576) | 2.17687646 |
| 73 | Chronic diarrhea (HP:0002028) | 2.16179246 |
| 74 | Vertigo (HP:0002321) | 2.15114740 |
| 75 | Hypochromic microcytic anemia (HP:0004840) | 2.13151044 |
| 76 | Thrombophlebitis (HP:0004418) | 2.10141760 |
| 77 | Bronchitis (HP:0012387) | 2.09038870 |
| 78 | Pulmonary fibrosis (HP:0002206) | 2.08145827 |
| 79 | Abnormality of eosinophils (HP:0001879) | 2.07644109 |
| 80 | Generalized aminoaciduria (HP:0002909) | 2.05835472 |
| 81 | Lymphoma (HP:0002665) | 2.05575112 |
| 82 | Abnormality of the pericardium (HP:0001697) | 2.02806872 |
| 83 | Recurrent sinusitis (HP:0011108) | 2.00603773 |
| 84 | Alveolar cell carcinoma (HP:0006519) | 2.00511992 |
| 85 | Increased serum ferritin (HP:0003281) | 1.99391120 |
| 86 | Keratitis (HP:0000491) | 1.95491408 |
| 87 | Restrictive lung disease (HP:0002091) | 1.93660908 |
| 88 | Joint swelling (HP:0001386) | 1.92332770 |
| 89 | Radial bowing (HP:0002986) | 1.90412270 |
| 90 | Recurrent otitis media (HP:0000403) | 1.90321771 |
| 91 | Increased IgE level (HP:0003212) | 1.89461453 |
| 92 | Episodic fever (HP:0001954) | 1.88085218 |
| 93 | Autoimmune thrombocytopenia (HP:0001973) | 1.87782579 |
| 94 | Hypoplasia of the thymus (HP:0000778) | 1.83007597 |
| 95 | Chronic otitis media (HP:0000389) | 1.79952762 |
| 96 | Hypochromic anemia (HP:0001931) | 1.79231390 |
| 97 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.77058179 |
| 98 | Increased corneal curvature (HP:0100692) | 1.76612330 |
| 99 | Keratoconus (HP:0000563) | 1.76612330 |
| 100 | Stomach cancer (HP:0012126) | 1.76514871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 5.30314234 |
| 2 | KDR | 3.79249462 |
| 3 | CDK19 | 3.41108554 |
| 4 | RIPK4 | 3.17172564 |
| 5 | TEC | 2.97044794 |
| 6 | MAP4K1 | 2.93375697 |
| 7 | BMPR2 | 2.77157237 |
| 8 | SCYL2 | 2.70557550 |
| 9 | TESK2 | 2.63929726 |
| 10 | GRK6 | 2.52748667 |
| 11 | ITK | 2.41134863 |
| 12 | CSK | 2.37718145 |
| 13 | MAP3K12 | 2.24366960 |
| 14 | JAK3 | 2.21149776 |
| 15 | BTK | 2.13815668 |
| 16 | BLK | 2.08567707 |
| 17 | TAOK3 | 2.05951584 |
| 18 | ZAP70 | 1.99842395 |
| 19 | TYK2 | 1.98359509 |
| 20 | PIK3CG | 1.96959095 |
| 21 | SYK | 1.76555641 |
| 22 | LYN | 1.67436027 |
| 23 | TLK1 | 1.65768974 |
| 24 | FES | 1.64800457 |
| 25 | ZAK | 1.48132896 |
| 26 | JAK2 | 1.43057943 |
| 27 | TBK1 | 1.42906749 |
| 28 | LCK | 1.42896909 |
| 29 | CSF1R | 1.38981349 |
| 30 | MYLK | 1.33274903 |
| 31 | JAK1 | 1.31325076 |
| 32 | IKBKE | 1.28846520 |
| 33 | CDK8 | 1.28641716 |
| 34 | KIT | 1.26805016 |
| 35 | TRPM7 | 1.24975818 |
| 36 | LRRK2 | 1.20967711 |
| 37 | HCK | 1.15602107 |
| 38 | MAP3K10 | 1.14867639 |
| 39 | IRAK4 | 1.14711094 |
| 40 | GRK1 | 1.04517312 |
| 41 | MAP3K11 | 1.02761938 |
| 42 | IKBKB | 0.99991535 |
| 43 | ERN1 | 0.93271128 |
| 44 | CAMKK2 | 0.92463545 |
| 45 | NEK9 | 0.86078016 |
| 46 | FYN | 0.85742920 |
| 47 | SIK3 | 0.85346202 |
| 48 | MATK | 0.84629706 |
| 49 | FGR | 0.83809347 |
| 50 | OXSR1 | 0.83774275 |
| 51 | ILK | 0.80971191 |
| 52 | MAP3K14 | 0.77684274 |
| 53 | PIM1 | 0.76936271 |
| 54 | IRAK1 | 0.72502114 |
| 55 | ERBB3 | 0.69732711 |
| 56 | ROCK1 | 0.67114513 |
| 57 | IGF1R | 0.66954690 |
| 58 | ADRBK2 | 0.66904605 |
| 59 | FRK | 0.63564203 |
| 60 | ERBB2 | 0.63523653 |
| 61 | GRK7 | 0.61907329 |
| 62 | PRKD3 | 0.61306253 |
| 63 | TAOK2 | 0.59961291 |
| 64 | PRKCH | 0.57854307 |
| 65 | CAMKK1 | 0.57571161 |
| 66 | EPHB1 | 0.55291212 |
| 67 | MAP3K1 | 0.55052355 |
| 68 | ABL1 | 0.51972406 |
| 69 | PASK | 0.51074915 |
| 70 | MAP2K6 | 0.50215197 |
| 71 | CDK4 | 0.49819551 |
| 72 | MAP2K3 | 0.48630378 |
| 73 | PTK2B | 0.48232768 |
| 74 | MARK3 | 0.47980055 |
| 75 | TIE1 | 0.46828933 |
| 76 | MAP3K5 | 0.46311510 |
| 77 | PRKCD | 0.46254784 |
| 78 | PKN1 | 0.44500768 |
| 79 | PAK1 | 0.43654237 |
| 80 | PRKD2 | 0.43230879 |
| 81 | PRKCQ | 0.41738725 |
| 82 | MAP4K2 | 0.41731021 |
| 83 | WNK1 | 0.40376568 |
| 84 | TNK2 | 0.38291123 |
| 85 | PDK1 | 0.36123067 |
| 86 | HIPK2 | 0.35562059 |
| 87 | MAP3K7 | 0.35339917 |
| 88 | EGFR | 0.34996443 |
| 89 | TESK1 | 0.33753887 |
| 90 | DAPK3 | 0.33599062 |
| 91 | NUAK1 | 0.30543019 |
| 92 | RPS6KA5 | 0.29957739 |
| 93 | VRK1 | 0.29336580 |
| 94 | DYRK1B | 0.27894552 |
| 95 | PRKCA | 0.27731901 |
| 96 | PAK4 | 0.23798117 |
| 97 | PRKD1 | 0.23781573 |
| 98 | ADRBK1 | 0.21760689 |
| 99 | PRPF4B | 0.20580353 |
| 100 | LATS1 | 0.20359997 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.14295282 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.73004588 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.72747084 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.67927274 |
| 5 | Asthma_Homo sapiens_hsa05310 | 3.34334716 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.09349674 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.86745513 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.75784692 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.63485211 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.58203211 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.58079341 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.53801330 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.48590083 |
| 14 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.29690736 |
| 15 | Malaria_Homo sapiens_hsa05144 | 2.25626446 |
| 16 | Viral myocarditis_Homo sapiens_hsa05416 | 2.00588393 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.98617848 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.96698360 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.82875987 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.75018411 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.66715127 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.65792368 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.56103635 |
| 24 | Proteasome_Homo sapiens_hsa03050 | 1.47606590 |
| 25 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.40391164 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.38489162 |
| 27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.32848504 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.28041038 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.23078190 |
| 30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.22225181 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19793496 |
| 32 | Salmonella infection_Homo sapiens_hsa05132 | 1.16295710 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.14562284 |
| 34 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.07764352 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05779455 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.02520255 |
| 37 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.01095313 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98033189 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.97506159 |
| 40 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.96273838 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 0.95404075 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 0.94569822 |
| 43 | Parkinsons disease_Homo sapiens_hsa05012 | 0.93208431 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.86705134 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.85907278 |
| 46 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.84519254 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 0.81656676 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.81451505 |
| 49 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.80056584 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.75633504 |
| 51 | Ribosome_Homo sapiens_hsa03010 | 0.73223019 |
| 52 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.72984037 |
| 53 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.69916859 |
| 54 | Olfactory transduction_Homo sapiens_hsa04740 | 0.67603269 |
| 55 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.63697216 |
| 56 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.59511124 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58047412 |
| 58 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.52690470 |
| 59 | Endocytosis_Homo sapiens_hsa04144 | 0.52520455 |
| 60 | Alzheimers disease_Homo sapiens_hsa05010 | 0.50722937 |
| 61 | Apoptosis_Homo sapiens_hsa04210 | 0.48199045 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47509624 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46449455 |
| 64 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45044964 |
| 65 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.42137383 |
| 66 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41151561 |
| 67 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.40697074 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.39578908 |
| 69 | Phototransduction_Homo sapiens_hsa04744 | 0.38552966 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.37229411 |
| 71 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36981698 |
| 72 | HTLV-I infection_Homo sapiens_hsa05166 | 0.34551904 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.31397061 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.30428175 |
| 75 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.29656427 |
| 76 | Hepatitis B_Homo sapiens_hsa05161 | 0.28267135 |
| 77 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.27432771 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.27163983 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27036175 |
| 80 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.26199431 |
| 81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.22684190 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.22057665 |
| 83 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.18606885 |
| 84 | Taste transduction_Homo sapiens_hsa04742 | 0.17686979 |
| 85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.17524228 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.15907923 |
| 87 | Huntingtons disease_Homo sapiens_hsa05016 | 0.15318245 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.13032530 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.11097840 |
| 90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.11081054 |
| 91 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.09563207 |
| 92 | Peroxisome_Homo sapiens_hsa04146 | 0.09242586 |
| 93 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.07317303 |
| 94 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.07105590 |
| 95 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.06377537 |
| 96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.06359929 |
| 97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.06248491 |
| 98 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.05426019 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.05250514 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.04599425 |

